Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01500304 · ClinicalTrials.gov registry record · NA
Minimally Invasive Groin Dissection for Melanoma
A NA study of Melanoma, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 11
- Study locations
NCT01500304 is a NA study of Melanoma that has completed, run by Mayo Clinic. The registered enrollment target is 88 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (88% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT01500304, a NA study of Melanoma, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this this study is to determine if a structured educational training program is successful in teaching surgeons a new operative technique. It will then be determined if this new operative technique is safe.
Conditions Studied
Interventions
- PROCEDURE Minimally invasive inguinal lymph node dissection
Study Locations (11)
Florida
- Mayo Clinic in Florida - Jacksonville
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Ohio
- MetroHealth Medical Center - Cleveland
- The Ohio State University Medical Center - Columbus
Arizona
- Mayo Clinic in Arizona - Scottsdale
California
- John Wayne Cancer Institute - Santa Monica
Illinois
- Northwestern Memorial Hospital - Chicago
New York
- Memorial Sloan Kettering Cancer Center - New York
North Carolina
- Duke University Medical Center - Durham
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01500304
The ClinicalTrials.gov registry entry for NCT01500304 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (88% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Minimally invasive inguinal lymph node dissection is the first listed.
NCT01500304 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Florida, Ohio, Arizona.
Frequently Asked Questions
What is clinical trial NCT01500304 about?
NCT01500304 is a clinical study titled "Minimally Invasive Groin Dissection for Melanoma". The purpose of this this study is to determine if a structured educational training program is successful in teaching surgeons a new operative technique. It will then be determined if this new operative technique is safe.
What is the current status of trial NCT01500304?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2012-06. Estimated completion is 2015-12.
What conditions does trial NCT01500304 study?
This clinical trial studies the following conditions: Melanoma.
What interventions are being tested in trial NCT01500304?
The interventions under investigation include: Minimally invasive inguinal lymph node dissection (PROCEDURE).
Who is sponsoring clinical trial NCT01500304?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01500304 being conducted?
This trial has 11 study locations across Arizona, California, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.